Occurrence of Hypercalciuria in Patients with Osteoporosis Treated with Teriparatide

Abstract

Urinary calcium excretion was increased with TPTD treatment for up to 12 months, compared with placebo and baseline values, but the magnitude of these changes is unlikely to be clinically relevant or warrant urinary calcium monitoring for most patients.